Synlab launches Frankfurt IPO after strong 2020

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity IPOs

Synlab launches Frankfurt IPO after strong 2020

Aidan Gregory
April 07, 2021 12:00 pm
Synlab_alamy_575_375
2D8RBPG A researcher putting PCR tubes on the thermal cycler for DNA amplification. Coronavirus PCR test. | Alamy Stock Photo

Synlab, the German laboratory diagnostic services company, has announced its intention to float on the Frankfurt Stock Exchange.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Deutsche BankJP MorganEquity IPOsHealth and BiotechEquityBarclaysEMEAJefferies LLCGermanyBNP ParibasLevFinEuropeUniCreditPrivate EquitySRIGoldman Sachs
AG
Aidan Gregory
Gift this article